Genetic embryo testing, and Germany’s nuclear predicament
Elizabeth Carr is head of commercial development at Genomic Prediction, a genetic testing startup that says it will assess embryos created in IVF clinics for their future chance of common diseases and then rank them, so parents can pick the one with the best future. It’s a controversial area that has some critics anguishing over the prospect of consumer eugenics. Still, word of the company’s “health scores” for embryos is spreading via media reports and as the company starts to promote the tests to IVF clinics and at…